Invyncible review
Invyncible pairs cheaper compounded semaglutide ($192.50/mo) or tirzepatide ($210/mo) with the option to move to an FDA-approved Wegovy or Zepbound pen on the same account — a real dual-modality option most competitors don't offer — but availability by state isn't disclosed until intake.
Every medical claim in this piece is footnoted to the record it came from — the trial or the FDA label — so you can read the source rather than take the masthead's word for it. No one on this desk is your clinician.
Invyncible at a glance
- Semaglutide
- $192.50/mo
- Tirzepatide
- $210/mo
- Coverage
- Not publicly disclosed; confirmed during intake
- Brand-name
- Yes
How we scored Invyncible
Each factor is scored from Invyncible's real pricing, disclosures and oversight, then combined into the 46/100 Editors' Rating by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
Cost is unpredictable, premium, or hides behind a plan commitment.
Limited public detail on who oversees care and how.
The headline rate obscures a plan requirement or a hidden step-up.
Little here is shaped around a mother's week or her life stage.
Support is thin once the prescription ships.
Leaving costs you — notice windows, minimum terms or fees you don't get back.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- www.invyncible.com/semaglutide-programs
Florida-based; discloses its corporate parent and street address, plus a LegitScript seal — more transparent than most compounded-only competitors reviewed on this site. Every price on its programs pages reads as a permanent 'sale' against a higher reference price rather than a limited-time promo, so the sale figure is recorded as the standing price since it's what the checkout flow actually uses. Sells both compounded programs and FDA-approved brand Wegovy/Zepbound on the same account. No state list published. No FDA warning letter found for Invyncible in a dedicated search or WLR's consolidated enforcement index.
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $192.5 | Standard FormulaPriced at $192.50 against a $275.00 reference figure. Add-on Glycine/B12 tiers run $149–$262.50/mo; brand-name Wegovy is sold direct at $1,750/mo (vs. $2,500 list). |
| Compounded tirzepatide | $210 | Standard FormulaPriced at $210.00 against a $300.00 reference figure. Add-on tiers run $180–$260/mo; brand-name Zepbound is sold direct at $1,540/mo (vs. $2,200 list). |
Swipe the table to see plan details →
HSA/FSA is commonly accepted for GLP-1 telehealth — check your plan. Prices reflect Invyncible's public disclosures at last review and change often; confirm the current number on Invyncible's own site.
What we like
- Names its corporate parent and a physical address rather than hiding behind a trade name
- LegitScript-verified
- Both compounded programs and FDA-approved brand-name Wegovy/Zepbound sold on one account
- No long-term commitment; cancel anytime per its own FAQ
The caveats
- No state-availability list — confirmed only during intake
- Every price is displayed as a permanent 'sale' against a higher reference figure that never appears to actually apply
- Brand-name pricing ($1,540–$1,750/mo) still runs well above most insurance-backed options
- Nothing on the site addresses pregnancy or breastfeeding timing
Invyncible for mothers: our verdict
Invyncible pairs cheaper compounded semaglutide ($192.50/mo) or tirzepatide ($210/mo) with the option to move to an FDA-approved Wegovy or Zepbound pen on the same account — a real dual-modality option most competitors don't offer — but availability by state isn't disclosed until intake. It runs about $192.5/month — a premium to the category, so the extras have to earn it.
We weigh Invyncible the way mothers actually have to: not just the real monthly cost, but the real monthly cost once the dose climbs and whether a real clinician stands behind it — the parts a generic weight-loss review skips.
What Invyncible actually costs
- Compounded semaglutide — Standard Formula: $192.5/mo
- Compounded tirzepatide — Standard Formula: $210/mo
For context, the typical ongoing price across our roster is around $162/month, so Invyncible sits at the premium end.
The medications Invyncible prescribes
Invyncible prescribes semaglutide and tirzepatide — the two molecules with the strongest published weight-loss outcomes, and having both on one account matters when insulin resistance (common with PCOS and after gestational diabetes) makes tirzepatide the better-suited option. It can route you to FDA-approved brand pens as well as compounded versions — the on-label products carry the manufacturer's own pregnancy and lactation labeling, which is cleaner to hand to an OB.
Where Invyncible fits — and where it doesn't — for mothers
A good fit if…
- you may need to move between semaglutide and tirzepatide as your body and hormones change.
Look elsewhere if…
- you'd rather a prescriber talk through timing around the real monthly cost once the dose climbs — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and oversight
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our Editors' Rating methodology.
One line that applies to every provider on this masthead: no GLP-1 is established as safe in pregnancy or while breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the timing decision belongs to you and your clinician.
The bottom line
Invyncible is a reasonable option — weigh it on the real monthly cost once the dose climbs and whether a real clinician stands behind it against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: A mother who wants the option to start compounded and later switch to a brand-name pen without changing providers, and who values a disclosed corporate parent and address.
Alternatives to Invyncible
Providers we have a referral relationship with, ordered by their Editors' Rating — highest first. A fee never moves a rating, but it does decide who appears here, so this is not the whole roster: the full ranking lists every provider we cover.
- Visit CoreAge RxCoreAge RxOur #1 pick
The one program on this masthead whose number still makes sense at the top of the dose. A flat, all-in monthly price on both molecules, no teaser rate to expire, and a cancel button you can actually find — the closest thing to a family-budget guarantee we've reviewed.
- Visit Gala Health
A flat $179 for either molecule and a genuinely gentle microdosing tier — a reasonable, all-doses-included option, if you can live with a yearly plan and a pharmacy the marketing never names.
- Visit Sesame
A high-trust telehealth marketplace that took a clear side: FDA-approved brand GLP-1 only, no compounded shortcut. You pay a brand cash price and book a real video visit — but you get on-label pens and one of the cleaner reputations on this masthead.
Keep comparing Invyncible
Head-to-head & alternatives
Invyncible, answered
- How much does Invyncible cost?
- As last verified, Invyncible's compounded pricing starts around $192.5/month ($192.50/mo semaglutide, $210/mo tirzepatide). Confirm the current, all-in price on Invyncible's own site before you commit.
- Is Invyncible safe to use while breastfeeding?
- No GLP-1 — compounded or brand — is established as safe during pregnancy or breastfeeding, and the labels advise against use; Invyncible is no exception. Plan any GLP-1 for after weaning, and discuss the timing with your own clinician.
- Does Invyncible offer both semaglutide and tirzepatide?
- Yes — Invyncible offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
- Where does Invyncible rank for mothers?
- Invyncible scores 46/100 on our Editors' Rating (rank #128), which weights six factors that matter for mothers. Our #1 pick, CoreAge Rx, leads the ranking — see how they compare.
Pricing, states and verification reflect Invyncible's public disclosures at last review; the Editors' Rating is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.